首页> 外文期刊>Asian Journal of Chemistry: An International Quarterly Research Journal of Chemistry >Visible Spectrophotometric Determination of Olmesartan Medoxomil in Pharmaceutical Formulations
【24h】

Visible Spectrophotometric Determination of Olmesartan Medoxomil in Pharmaceutical Formulations

机译:可见光分光光度法测定药物制剂中奥美沙坦酯的含量

获取原文
获取原文并翻译 | 示例
       

摘要

Two simple and sensitive spectrophotometric methods (method A and method B) in the visible region have been developed for determination of olmesartan medoxomil in bulk and in pharmaceutical formulations. Method A is based on oxidative coupling of olmesartan medoxomil with 3-methylbenzothiazolin-2-one hydrazone (MBTH). The resulting green complex has λ_(max) at 631 nm. Method B is based on the reduction of ferric to ferrous ions followed by complexation with 1,10-phenanthroline to produce an orange red chromogen at λ_(max) 510 nm. Beers law is obeyed in the concentration range of 10-45 μg/mL and 5-35 μg/mL respectively. These methods were extended to pharmaceutical formulations and there was no interference from excepients and diluents. The proposed methods are simple, sensitive, accurate and suitable for quality control applications.
机译:已开发了可见光区域的两种简单而灵敏的分光光度法(方法A和方法B),用于测定散装制剂和药物制剂中的奥美沙坦medoxomil。方法A基于奥美沙坦酯与3-甲基苯并噻唑啉-2-一(MBTH)的氧化偶联。所得的绿色络合物在631nm处具有λ_(max)。方法B基于将铁离子还原为亚铁离子,然后与1,10-菲咯啉络合以在λ_(max)510 nm处产生橙红色色原。在10-45μg/ mL和5-35μg/ mL的浓度范围内分别遵守啤酒法。这些方法已扩展到药物制剂,并且不会受到赋形剂和稀释剂的干扰。所提出的方法简单,灵敏,准确,适合于质量控制应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号